CXCR4 as a Predictor of Response in Acute Myeloid Leukemia

被引：0
作者：
Pastore, Domenico
Mestice, Anna
Giannoccaro, Margherita
Liso, Arcangelo
Martelli, Maria Paola
Carluccio, Paola
Albano, Francesco
Delia, Mario
Rossi, Antonella Russo
Leo, Manuela
Pannunzio, Alessandra
Liso, Vincenzo
Falini, Brunangelo
Specchia, Giorgina
机构：
来源：
BLOOD | 2008年 / 112卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1011 / 1011
页数：1
相关论文
共 50 条
[31]   Targeting the CXCL12/CXCR4 axis in acute myeloid leukemia: from bench to bedside [J].
Cho, Byung-Sik ;
Kim, Hee-Je ;
Konopleva, Marina .
KOREAN JOURNAL OF INTERNAL MEDICINE, 2017, 32 (02) :248-257
[32]   Nanomicelles co-loading CXCR4 antagonist and doxorubicin combat the refractory acute myeloid leukemia [J].
Zhang, Meichen ;
Ge, Yangyang ;
Xu, Shilin ;
Fang, Xiaocui ;
Meng, Jie ;
Yu, Lanlan ;
Wang, Chenxuan ;
Liu, Jian ;
Wen, Tao ;
Yang, Yanlian ;
Wang, Chen ;
Xu, Haiyan .
PHARMACOLOGICAL RESEARCH, 2022, 185
[33]   Identification of CXCR4 Expression By Targeted PET/MR Imaging in Patients with Acute Myeloid Leukemia (AML) [J].
Herhaus, Peter ;
Habringer, Stefan ;
Philipp-Abbrederis, Kathrin ;
Vag, Tibor ;
Gerngross, Carlos ;
Hoellein, Alexander ;
Altmann, Torben ;
Mueller-Thomas, Catharina ;
Slotta-Huspenina, Julia ;
Peschel, Christian ;
Schwaiger, Markus ;
Wester, Hans-Juergen ;
Verbeek, Mareike ;
Spiekermann, Karsten ;
Goetze, Katharina ;
Keller, Ulrich .
BLOOD, 2015, 126 (23)
[34]   Notch/CXCR4 Partnership in Acute Lymphoblastic Leukemia Progression [J].
Tsaouli, Georgia ;
Ferretti, Elisabetta ;
Bellavia, Diana ;
Vacca, Alessandra ;
Felli, Maria Pia .
JOURNAL OF IMMUNOLOGY RESEARCH, 2019, 2019
[35]   CXCR7 Is Highly Expressed in Acute Lymphoblastic Leukemia and Potentiates CXCR4 Response to CXCL12 [J].
Carvalho Melo, Rita de Cassia ;
Longhini, Ana Leda ;
Bigarella, Carolina Louzao ;
Baratti, Mariana Ozello ;
Traina, Fabiola ;
Favaro, Patricia ;
Campos, Paula de Melo ;
Olalla Saad, Sara Teresinha .
PLOS ONE, 2014, 9 (01)
[36]   Engraftment of acute myeloid leukemia in NOD/SCID mice is independent of CXCR4 and predicts poor patient survival [J].
Monaco, G ;
Konopleva, M ;
Munsell, M ;
Leysath, C ;
Wang, RY ;
Jackson, CE ;
Korbling, M ;
Estey, E ;
Belmont, J ;
Andreeff, M .
STEM CELLS, 2004, 22 (02) :188-201
[37]   Significance of CXCL12/CXCR4 Ligand/Receptor Axis in Various Aspects of Acute Myeloid Leukemia [J].
Yazdani, Zinat ;
Mousavi, Zahra ;
Moradabadi, Alireza ;
Hassanshahi, Gholamhossein .
CANCER MANAGEMENT AND RESEARCH, 2020, 12 :2155-2165
[38]   Association of CXCR4 Expression and Clinical Outcome in Different Subsets of De Novo Acute Myeloid Leukemia Patients [J].
Rady, Asmhan S. ;
Badawy, Ragia H. ;
El Gamal, Basma M. ;
Darwish, Amira D. ;
Aziz, Rania S. Abdel ;
El Gammal, Mosaad ;
Goweda, Reda A. .
CLINICAL LABORATORY, 2020, 66 (03) :401-408
[39]   A phase 1/2 study of chemosensitization with the CXCR4 antagonist plerixafor in relapsed or refractory acute myeloid leukemia [J].
Uy, Geoffrey L. ;
Rettig, Michael P. ;
Motabi, Ibraheem H. ;
McFarland, Kyle ;
Trinkaus, Kathryn M. ;
Hladnik, Lindsay M. ;
Kulkarni, Shashikant ;
Abboud, Camille N. ;
Cashen, Amanda F. ;
Stockerl-Goldstein, Keith E. ;
Vij, Ravi ;
Westervelt, Peter ;
DiPersio, John F. .
BLOOD, 2012, 119 (17) :3917-3924
[40]   The CXCL12/CXCR4 Pathway As a Potential Target of Tipifarnib in Acute Myeloid Leukemia and Myelodysplastic Syndromes [J].
Gualberto, Antonio ;
Scholz, Catherine ;
Janes, Matthew R. ;
Kessler, Linda ;
Raza, Azra .
BLOOD, 2017, 130
12345